Guangdong Marubi Financials
| 603983 Stock | 29.15 0.98 3.48% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | 273.2 M | 200.4 M |
|
|
Guangdong | Select Account or Indicator |
Understanding current and past Guangdong Marubi Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Guangdong Marubi's financial statements are interrelated, with each one affecting the others. For example, an increase in Guangdong Marubi's assets may result in an increase in income on the income statement.
Please note, the presentation of Guangdong Marubi's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Guangdong Marubi's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Guangdong Marubi's management manipulating its earnings.
Guangdong Marubi Stock Summary
Guangdong Marubi competes with Beijing Wantai, Aluminum Corp, COL Digital, Shaanxi Meineng, and Gansu Huangtai. Guangdong Marubi is entity of China. It is traded as Stock on SHG exchange.Specialization | Consumer Defensive, Household & Personal Products |
| Instrument | China Stock View All |
| Exchange | Shanghai Stock Exchange |
| ISIN | CNE100003M51 |
| Business Address | South Tower, Polyway |
| Sector | Personal Care Products |
| Industry | Consumer Staples |
| Benchmark | Dow Jones Industrial |
| Website | www.marubi.cn |
| Phone | 86 20 6637 8666 |
You should never invest in Guangdong Marubi without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Guangdong Stock, because this is throwing your money away. Analyzing the key information contained in Guangdong Marubi's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Guangdong Marubi Key Financial Ratios
Guangdong Marubi's financial ratios allow both analysts and investors to convert raw data from Guangdong Marubi's financial statements into concise, actionable information that can be used to evaluate the performance of Guangdong Marubi over time and compare it to other companies across industries.| Revenue | 2.23 B | ||||
| Gross Profit | 1.14 B | ||||
| EBITDA | 277.35 M | ||||
| Net Income | 259.42 M | ||||
| Total Asset | 4.45 B |
Guangdong Marubi Key Balance Sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 3.4B | 3.8B | 3.8B | 4.1B | 4.5B | 3.4B | |
| Other Current Liab | 296.0M | 369.6M | 349.8M | 4.5M | 20.0M | 19.0M | |
| Other Liab | 25.6M | 26.4M | 7.8M | 12.0M | 10.8M | 14.4M | |
| Net Tangible Assets | 1.3B | 2.7B | 3.0B | 2.3B | 2.7B | 2.0B | |
| Retained Earnings | 1.5B | 1.8B | 1.9B | 1.8B | 2.0B | 1.5B | |
| Accounts Payable | 212.8M | 203.1M | 198.4M | 229.8M | 262.6M | 246.6M | |
| Cash | 2.1B | 1.7B | 806.1M | 1.1B | 1.1B | 1.0B | |
| Other Assets | 38.3M | 40.9M | 798.8M | 562.0M | 646.3M | 678.6M | |
| Net Receivables | 5.6M | 5.2M | 57.4M | 69.8M | 28.0M | 38.2M | |
| Inventory | 187.0M | 138.3M | 138.4M | 151.7M | 171.7M | 156.2M | |
| Other Current Assets | 33.5M | 42.4M | 222.9M | 474.7M | 442.7M | 464.8M | |
| Total Liab | 766.4M | 794.4M | 603.2M | 841.6M | 1.0B | 838.7M | |
| Total Current Assets | 3.1B | 2.7B | 2.0B | 2.2B | 2.5B | 2.3B | |
| Intangible Assets | 17.7M | 18.6M | 764.6M | 748.6M | 719.6M | 755.6M | |
| Net Invested Capital | 2.7B | 3.1B | 3.1B | 3.4B | 3.4B | 2.8B | |
| Net Working Capital | 2.4B | 1.9B | 1.4B | 1.6B | 1.5B | 1.7B |
Guangdong Marubi Key Income Statement Accounts
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Tax Provision | 101.2M | 104.0M | 68.4M | 39.2M | 39.5M | 52.3M | |
| Net Interest Income | 22.2M | 57.3M | 34.1M | 14.0M | 15.1M | 24.6M | |
| Interest Income | 22.5M | 51.2M | 35.5M | 16.1M | 21.4M | 25.3M | |
| Interest Expense | 3.1M | 1.1M | 1.0M | 1.9M | 5.9M | 6.2M | |
| Total Revenue | 1.8B | 1.7B | 1.8B | 1.7B | 2.2B | 1.8B | |
| Gross Profit | 1.2B | 1.2B | 1.1B | 1.2B | 1.6B | 1.3B | |
| Operating Income | 571.4M | 487.5M | 250.3M | 173.4M | 200.4M | 273.2M | |
| Ebit | 411.8M | 525.6M | 437.9M | 250.3M | 287.8M | 407.4M | |
| Research Development | 44.9M | 50.2M | 50.5M | 52.9M | 62.3M | 47.8M | |
| Cost Of Revenue | 573.5M | 589.7M | 643.0M | 547.3M | 652.2M | 594.6M | |
| Income Before Tax | 614.0M | 567.4M | 309.6M | 206.6M | 317.1M | 314.1M | |
| Net Income | 514.9M | 464.4M | 247.9M | 174.2M | 259.4M | 262.0M | |
| Income Tax Expense | 74.3M | 101.2M | 104.0M | 68.4M | 78.7M | 81.4M | |
| Ebitda | 629.6M | 581.1M | 330.7M | 236.4M | 212.7M | 348.0M |
Guangdong Marubi Key Cash Accounts
Cash flow analysis captures how much money flows into and out of Guangdong Marubi Bio. It measures of how well Guangdong is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Guangdong Marubi brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Guangdong had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Guangdong Marubi has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (63.4M) | 42.8M | (14.0M) | (25.2M) | (33.1M) | (34.7M) | |
| Investments | (720M) | (75.7M) | (572.8M) | 70.1M | (215.2M) | (225.9M) | |
| Change In Cash | 538.1M | (444.5M) | (858.5M) | 263.5M | (22.4M) | (21.3M) | |
| Depreciation | 15.6M | 12.6M | 20.1M | 26.5M | 24.6M | 19.4M | |
| Capital Expenditures | 6.4M | 748.9M | 117.1M | 110.9M | 254.0M | 173.5M | |
| Net Income | 514.9M | 464.4M | 247.9M | 174.2M | 259.4M | 262.0M | |
| End Period Cash Flow | 2.1B | 1.7B | 798.5M | 1.1B | 1.0B | 1.0B | |
| Change To Netincome | (25.1M) | (20.9M) | (40.9M) | (13.2M) | (11.8M) | (12.4M) | |
| Free Cash Flow | 459.1M | (386.6M) | (124.6M) | (62.5M) | 84.0M | 94.2M | |
| Other Non Cash Items | 9.4M | 2.3M | 13.0M | 14.1M | 7.7M | 10.3M |
Guangdong Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Guangdong Marubi's current stock value. Our valuation model uses many indicators to compare Guangdong Marubi value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Guangdong Marubi competition to find correlations between indicators driving Guangdong Marubi's intrinsic value. More Info.Guangdong Marubi Biotechnology is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.38 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Guangdong Marubi Biotechnology is roughly 2.60 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Guangdong Marubi by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Guangdong Marubi's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Guangdong Marubi Bio Systematic Risk
Guangdong Marubi's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Guangdong Marubi volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Guangdong Marubi Bio correlated with the market. If Beta is less than 0 Guangdong Marubi generally moves in the opposite direction as compared to the market. If Guangdong Marubi Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Guangdong Marubi Bio is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Guangdong Marubi is generally in the same direction as the market. If Beta > 1 Guangdong Marubi moves generally in the same direction as, but more than the movement of the benchmark.
Guangdong Marubi Biotechnology Total Assets Over Time
Guangdong Marubi Thematic Clasifications
Guangdong Marubi Biotechnology is part of Biotech investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Biotechnology and pharmaceuticals production and services. Companies specialized in biotechnology production and delivery of pharmaceuticals services
This theme covers Biotechnology and pharmaceuticals production and services. Companies specialized in biotechnology production and delivery of pharmaceuticals services. Get More Thematic Ideas
| Biotech | View |
Guangdong Marubi December 2, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Guangdong Marubi help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Guangdong Marubi Biotechnology. We use our internally-developed statistical techniques to arrive at the intrinsic value of Guangdong Marubi Biotechnology based on widely used predictive technical indicators. In general, we focus on analyzing Guangdong Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Guangdong Marubi's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.6 | |||
| Information Ratio | 0.1036 | |||
| Maximum Drawdown | 15.94 | |||
| Value At Risk | (4.35) | |||
| Potential Upside | 5.93 |
Complementary Tools for Guangdong Stock analysis
When running Guangdong Marubi's price analysis, check to measure Guangdong Marubi's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guangdong Marubi is operating at the current time. Most of Guangdong Marubi's value examination focuses on studying past and present price action to predict the probability of Guangdong Marubi's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guangdong Marubi's price. Additionally, you may evaluate how the addition of Guangdong Marubi to your portfolios can decrease your overall portfolio volatility.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |